Breast enlargement

Breast enlargement is the enlargement of the breasts. It may occur naturally as in mammoplasia or may occur artificially through active intervention. Many women regard their breasts, which are female secondary sex characteristics, as important to their sexual attractiveness, as a sign of femininity that is important to their sense of self. Due to this, when a woman considers her breasts deficient in some respect, she might choose to engage in some activity intended to enhance them.[1]

Methods used in an effort to achieve larger breasts include:

  • Surgical breast augmentation, such as with breast implants or fat transfer.
  • Pharmacological or hormonal breast enhancement, through administration of medications such as estrogen or breast enlargement supplements.[2][3][4]
  • Increasing the food energy intake by eating more and/or more energetic foods. By increasing food energy intake, more adipose tissue will be created, part of which will consist of adipose tissue located near the breast area.[5] The amount of adipose tissue that will be added to the breasts varies from person to person and is controlled by the KLF14 gene.[6] Additional modification of the KLF14 gene can thus make sure even more of the adipose tissue increase will occur at the breasts.
  • Mechanical breast enhancement, such as through use of the BRAVA Breast Enhancement and Shaping System, a clinically-effective external breast tissue expander.[7]
  • Mark Eden bust developer, a fraudulently marketed method and device.

See also

References

Here we are talking about 'Breast Expansion Cream', which not only helps in developing breasts, but also acts as their toning and shaping.

  1. "Secondary sex characteristics". .hu-berlin.de. Retrieved 2011-10-31.
  2. Gunther Göretzlehner; Christian Lauritzen; Thomas Römer; Winfried Rossmanith (1 January 2012). Praktische Hormontherapie in der Gynäkologie. Walter de Gruyter. pp. 385–. ISBN 978-3-11-024568-4.
  3. R.E. Mansel; Oystein Fodstad; Wen G. Jiang (14 June 2007). Metastasis of Breast Cancer. Springer Science & Business Media. pp. 217–. ISBN 978-1-4020-5866-0.
  4. Hartmann BW, Laml T, Kirchengast S, Albrecht AE, Huber JC (1998). "Hormonal breast augmentation: prognostic relevance of insulin-like growth factor-I". Gynecol. Endocrinol. 12 (2): 123–7. doi:10.3109/09513599809024960. PMID 9610425.
  5. Katch, VL; Campaigne, B; Freedson, P; Sady, S; Katch, FI; Behnke, AR (July 1980). "Contribution of breast volume and weight to body fat distribution in females" (PDF). Am. J. Phys. Anthropol. 53 (1): 93–100. doi:10.1002/ajpa.1330530113. PMID 7416252.
  6. Small, KS; Hedman, AK; Grundberg, E; et al. (June 2011). "Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes". Nat. Genet. 43 (6): 561–4. doi:10.1038/ng.833. PMC 3192952. PMID 21572415.
  7. Schlenz, Ingrid; Kaider, Alexandra (2007). "The Brava External Tissue Expander: Is Breast Enlargement without Surgery a Reality?". Plastic and Reconstructive Surgery. 120 (6): 1680–1689. doi:10.1097/01.prs.0000267637.43207.19. ISSN 0032-1052. PMID 18040206.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.